tradingkey.logo

IDEXX Laboratories Inc

IDXX
628.540USD
+0.880+0.14%
Cierre 10/30, 16:00ETCotizaciones retrasadas 15 min
50.38BCap. mercado
51.11P/E TTM

IDEXX Laboratories Inc

628.540
+0.880+0.14%

Más Datos de IDEXX Laboratories Inc Compañía

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.

Información de IDEXX Laboratories Inc

Símbolo de cotizaciónIDXX
Nombre de la empresaIDEXX Laboratories Inc
Fecha de salida a bolsaJun 21, 1991
Director ejecutivoMr. Andrew Emerson
Número de empleados11000
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 21
DirecciónOne Idexx Drive
CiudadWESTBROOK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal04092-2041
Teléfono12075560300
Sitio Webhttps://www.idexx.com/
Símbolo de cotizaciónIDXX
Fecha de salida a bolsaJun 21, 1991
Director ejecutivoMr. Andrew Emerson

Ejecutivos de IDEXX Laboratories Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Independent Director
Independent Director
1.09K
+31.76%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
--
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
6.12K
+3.08%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
3.84K
+60.39%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
Otro
-697.43M
-62.86%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
717.87M
64.70%
Europe & Middle East & Africa (EMEA) (Region)
233.27M
21.03%
Asia Pacific
89.30M
8.05%
Canada
46.69M
4.21%
Latin America
22.33M
2.01%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
CAG Diagnostics recurring revenue
878.00M
79.14%
IDEXX VetLab consumables
375.11M
33.81%
Reference laboratory diagnostic and consulting services
367.69M
33.14%
Rapid assay products
100.24M
9.04%
CAG Diagnostics capital - instruments
85.85M
7.74%
Otro
-697.43M
-62.86%

Estadísticas de accionistas

Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.30%
BlackRock Institutional Trust Company, N.A.
6.63%
State Street Investment Management (US)
4.44%
Fundsmith LLP
3.30%
Geode Capital Management, L.L.C.
3.08%
Otro
70.25%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.30%
BlackRock Institutional Trust Company, N.A.
6.63%
State Street Investment Management (US)
4.44%
Fundsmith LLP
3.30%
Geode Capital Management, L.L.C.
3.08%
Otro
70.25%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
54.15%
Investment Advisor/Hedge Fund
32.38%
Research Firm
3.94%
Pension Fund
2.49%
Bank and Trust
2.04%
Hedge Fund
0.90%
Individual Investor
0.69%
Sovereign Wealth Fund
0.60%
Family Office
0.54%
Otro
2.27%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
2278
77.56M
96.93%
-3.76M
2025Q2
2277
79.81M
99.73%
-1.01M
2025Q1
2279
79.02M
98.21%
-512.23K
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
9.84M
12.3%
+19.20K
+0.20%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.30M
6.63%
-132.86K
-2.44%
Jun 30, 2025
State Street Investment Management (US)
3.55M
4.44%
-95.45K
-2.62%
Jun 30, 2025
Fundsmith LLP
2.64M
3.3%
-9.04K
-0.34%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.46M
3.08%
+54.40K
+2.26%
Jun 30, 2025
Baron Capital Management, Inc.
2.03M
2.54%
-27.16K
-1.32%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
1.65M
2.06%
-5.80K
-0.35%
Aug 31, 2025
Polen Capital Management, LLC
1.20M
1.49%
+1.12M
+1519.07%
Jun 30, 2025
Principal Global Investors (Equity)
1.13M
1.41%
+1.75K
+0.16%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
1.08M
1.35%
-10.27K
-0.94%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
ProShares Pet Care ETF
9.54%
iShares U.S. Medical Devices ETF
5.48%
First Trust Water ETF
5.43%
Hennessy Sustainable ETF
3.75%
Nuveen ESG Mid-Cap Growth ETF
3.53%
Adaptive Core ETF
2.75%
Invesco Raymond James SB-1 Equity ETF
2.49%
First Trust S&P 500 Economic Moat Index ETF
2.37%
SPDR S&P Health Care Equipment ETF
2.24%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
2.19%
Ver más
ProShares Pet Care ETF
Proporción9.54%
iShares U.S. Medical Devices ETF
Proporción5.48%
First Trust Water ETF
Proporción5.43%
Hennessy Sustainable ETF
Proporción3.75%
Nuveen ESG Mid-Cap Growth ETF
Proporción3.53%
Adaptive Core ETF
Proporción2.75%
Invesco Raymond James SB-1 Equity ETF
Proporción2.49%
First Trust S&P 500 Economic Moat Index ETF
Proporción2.37%
SPDR S&P Health Care Equipment ETF
Proporción2.24%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
Proporción2.19%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI